Patient scheduling for gonadotrophin-releasing hormone antagonist protocols (Q34591678)

3 August 2017

1 reference

title

Patient scheduling for gonadotrophin-releasing hormone antagonist protocols (English)

1 reference

3 August 2017

William L Ledger

0 references

1 February 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

G29-32; discussion G32-3, G41-8

1 reference

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Evaluation of different ovarian stimulation protocols for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1464727992000199801

10.1080/1464727992000199801

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference